Two Cases of Thyrotoxicosis and Euglycemic Diabetic Ketoacidosis Under Sodium-glucose Transport Protein 2 Inhibitor Treatment-Reference-Cited by-同舟云学术

Two Cases of Thyrotoxicosis and Euglycemic Diabetic Ketoacidosis Under Sodium-glucose Transport Protein 2 Inhibitor Treatment

Published:2022-10-15 Issue:20 Volume:61 Page:3069-3075
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Hitsuwari Takuhei¹,Tsurutani Yuya¹,Yamane Takahiro¹,Sunouchi Takashi¹,Horikoshi Hirofumi¹,Hirose Rei¹,Hoshino Yoshitomo¹,Watanabe Satoshi¹,Katsuragawa Sho¹,Saitou Jun¹

Affiliation:

1. Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/61/20/61_8830-21/_pdf

Reference37 articles.

1. 1. Zinman B, Wanner C, Lachin JM, et al.; EMPA-REG OUTCOME Investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373: 2117-2128, 2015.

2. 2. Neal B, Perkovic V, Mahaffey KW, et al.; CANVAS Program Collaborative Group. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med 377: 644-657, 2017.

3. 3. Wiviott SD, Raz I, Bonaca MP, et al.; DECLARE-TIMI 58 Investigators. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med 380: 347-357, 2019.

4. 4. Hage M, Zantout MS, Azar ST. Thyroid disorders and diabetes mellitus. J Thyroid Res 2011: 439463, 2011.

5. 5. Perros P, McCrimmon RJ, Shaw G, Frier BM. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med 12: 622-627, 1995.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SGLT2 inhibitor as a potential therapeutic approach in hyperthyroidism-induced cardiopulmonary injury in rats;Pflügers Archiv - European Journal of Physiology;2024-05-03

2. The Safety of Sodium Glucose Cotransporter 2 Inhibitors for the Elderly Diabetic Patients;Journal of Endocrinology and Metabolism;2023-11

3. Association of SGLT-2 Inhibitors with Thyroid Dysfunction: A Drug-Target Mendelian Randomization Study;2023-09-13

4. Empagliflozin;Reactions Weekly;2023-01-14

5. Side effects of insulin and other antihyperglycemic drugs;Side Effects of Drugs Annual;2023